M&A / Property
Ndatalyze tests sports predictive scoring formulas

NDAT · Price
Executive Summary
- Ndatalyze Corp. reports that its “Epitome” predictive sports performance analytics platform is in testing, with live online questionnaire and data collection from junior league teams slated to start mid‑October 2026 and finish by year‑end 2025.
- The company confirms the reverse takeover (RTO) remains pending; audit of the target continues and the controlling shareholder awaits a tax opinion before finalizing the private placement amount.
- Share trading will stay halted until the RTO is either completed or formally abandoned.
Key Details
- Epitome Project:
- Predictive scoring formulas incorporating genetic markers are undergoing testing and calibration.
- Online questionnaire (“Epitome”) is live and in testing phase.
- Data collection planned from three junior league teams (WHL and equivalents) beginning ~mid‑October 2026, with completion targeted before Dec 31 2025.
-
Machine learning tools have reduced development costs and accelerated timelines.
-
Reverse Takeover (RTO) Update:
- Audit of the RTO target is still in progress.
- Controlling shareholder awaiting a tax opinion to determine final private placement amount; timing of receipt unknown.
- Trading of Ndatalyze Corp. shares remains halted pending RTO outcome (completion or abandonment).
Notable Quotes
- None provided in the release.
More from Ndatalyze Corp
May 15, 2026 · 17:05